Breast Cancer Clinical Trials in Raleigh, NC

View the best 10 breast cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Breast Cancer clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for breast cancer in Raleigh, North Carolina

ADJUVANT ENDOCRINE THERAPY

Hormone Therapy

Recruiting1 awardPhase 2

This trial is studying a combination of HER2-directed therapies and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer.

Endocrine Therapy of Physician's Choice +1 More

Hormone Therapy

Recruiting2 awardsPhase 3

This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.

Giredestrant +1 More

Hormone Therapy

Recruiting2 awardsPhase 3

This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.

Paclitaxel +4 More

Chemotherapy

Recruiting2 awardsPhase 3

This trial is testing whether a combination of two drugs is more effective than one drug for patients with advanced breast cancer. The drugs work by blocking signals that help cancer cells grow. The study focuses on patients whose cancer cannot be cured with surgery or other local treatments.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

Recruiting2 awardsPhase 3

This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.

Stereotactic Radiosurgery +1 More

Radiation

Recruiting1 awardPhase 1 & 2

This trial is testing a combination of focused radiation, olaparib, and immunotherapy for patients with specific types of breast cancer that have spread to the brain. The treatment aims to kill cancer cells, make them more vulnerable, and boost the body's immune response. Olaparib has shown promising results in various cancers.

SRG-514

Cancer Vaccine

Recruiting1 awardPhase 1

This trial is the first time a new drug called SRG-514 is being tested on humans. The goal is to figure out the best dose of SRG-514 to give to patients having breast

LY4101174

Monoclonal Antibodies

Recruiting1 awardPhase 1

"This trial is testing a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors. The trial has two parts and will take about 4 years to

Alisertib

Anti-mitotic agent

Recruiting1 awardPhase 2

This trial is testing a drug called alisertib in combination with endocrine therapy for patients with a specific type of breast cancer that has spread. The study aims to find the best dose of al

CONSYDER

Recruiting1 award

This trial aims to improve the decision-making process for young women with breast cancer by using a web-based tool called CONSYDER. Participants will complete surveys before and after surgery, and some may be interviewed

Popular Filters

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Conditions

Locations

Psychology Related

Treatments

Cities

Breast Cancer Clinical Trials in Raleigh, NC

Trials in Raleigh, North Carolina

ADJUVANT ENDOCRINE THERAPY

Hormone Therapy

This trial is studying a combination of HER2-directed therapies and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer.

Endocrine Therapy of Physician's Choice +1 More

Hormone Therapy

Giredestrant +1 More

Hormone Therapy

This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.

Paclitaxel +4 More

Chemotherapy

This trial is testing whether a combination of two drugs is more effective than one drug for patients with advanced breast cancer. The drugs work by blocking signals that help cancer cells grow. The study focuses on patients whose cancer cannot be cured with surgery or other local treatments.

Camizestrant

Selective Estrogen Receptor Degrader (SERD)

This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.

Stereotactic Radiosurgery +1 More

Radiation

SRG-514

Cancer Vaccine

This trial is the first time a new drug called SRG-514 is being tested on humans. The goal is to figure out the best dose of SRG-514 to give to patients having breast

LY4101174

Monoclonal Antibodies

"This trial is testing a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors. The trial has two parts and will take about 4 years to

Alisertib

Anti-mitotic agent

This trial is testing a drug called alisertib in combination with endocrine therapy for patients with a specific type of breast cancer that has spread. The study aims to find the best dose of al

CONSYDER

This trial aims to improve the decision-making process for young women with breast cancer by using a web-based tool called CONSYDER. Participants will complete surveys before and after surgery, and some may be interviewed

Popular Filters

Phase 3 Trials

Selective Estrogen Receptor Degrader

Elacestrant for Breast Cancer

"This trial aims to compare a new drug called elacestrant with the usual hormone therapy for early breast cancer patients with a high risk of cancer coming back. The study will see which treatment is more

CDK4/6 Inhibitor

CDK4/6 Inhibitors for Metastatic Breast Cancer

"This trial aims to find a better dosing strategy for CDK4/6 inhibitors in older patients with Metastatic Breast Cancer to help them tolerate side effects and stay on treatment longer. The study

Selective Estrogen Receptor Degrader (SERD)

Camizestrant for Early Breast Cancer

This trial is testing camizestrant, a drug that blocks estrogen, in patients with ER+/HER2- early breast cancer at medium to high risk of recurrence. The goal is to see if it works better than standard hormone treatments by stopping cancer cells from growing.

Hormone Therapy

Giredestrant vs. Fulvestrant for Advanced Breast Cancer

This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.

Chemotherapy

Durvalumab + Chemotherapy for Breast Cancer

This trial will compare the effects of adding an immunotherapy drug (durvalumab) to usual chemotherapy to usual chemotherapy alone in treating breast cancer.

Chemotherapy

DB-1303 for Breast Cancer

This trial will compare the effectiveness of two treatments for HR+/HER2- breast cancer in terms of progression-free survival.

Trials With No Placebo

Anti-mitotic agent

Alisertib + Endocrine Therapy for Breast Cancer

This trial is testing a drug called alisertib in combination with endocrine therapy for patients with a specific type of breast cancer that has spread. The study aims to find the best dose of al

Mobile Health App for Breast Cancer

This trial examines how helpful and satisfying it is to use a mobile health app in clinics for Black or African American women with breast cancer. The app was designed to provide education and communication about clinical trials and

CAR T-cell Therapy

CAR-T Cell Therapy for Relapsing Breast Cancer

This trial is testing the safety of increasing doses of a type of immune cell therapy called CAR-T cells in patients with a specific type of breast cancer that has come back or not responded to treatment.

Behavioural Intervention

Physical Activity Program for Breast and Colon Cancer Survivors

"This trial aims to see if using a physical activity index screener, exercise coaching, and self-monitoring can help breast or colon cancer patients increase physical activity and reduce time spent sitting or being inactive."

Cancer Vaccine

SRG-514 for Breast Cancer

This trial is the first time a new drug called SRG-514 is being tested on humans. The goal is to figure out the best dose of SRG-514 to give to patients having breast

Cancer Vaccine

NM32-2668 for Advanced Cancer

This trial is testing a new drug called NM32-2668 in adult patients with advanced solid tumors. The main goals are to check the safety and effectiveness of the drug, find the highest safe dose

View More Related Trials

View more breast-cancer clinical trials raleigh

Frequently Asked Questions

Other Trials to Consider

Polyethylene glycol (PEG)

Temozolomide

Docetaxel

Placebo

Minimal Contact-Cognitive Behavior Therapy

Gedatolisib

Tirzepatide

PRT2527

Placebo